# IM8 (David Beckham & Danny Yeung's health drink startup)

> IM8 is a premium longevity supplement brand co-founded by soccer icon David Beckham and serial entrepreneur Danny Yeung, operating as a consumer-health subsidiary of Nasdaq-listed Prenetics. In July 2026, IM8 secured $1 billion in growth financing from General Catalyst's Customer Value Fund (CVF), a non-dilutive facility that funds up to 70% of customer-acquisition spend in exchange for a capped share of cohort revenue rather than equity. Launched in December 2024, IM8 became the fastest-growing premium supplement brand on record, hitting roughly $100 million in annualized revenue within eleven months, and the capital is meant to pour fuel on marketing while ownership stays undiluted.

## Achievements

- Fastest-growing premium supplement brand ever recorded.
- Reached approximately $100 million in annualized revenue within eleven months of launch.
- Secured $1 billion in non-dilutive growth financing from General Catalyst's CVF in July 2026.
- Delivered over 50 million servings since launch, at roughly 200,000 servings per day.
- Averaging one customer order every 27 seconds.
- Products NSF Certified for Sport; non-GMO, vegan, and allergen-free.
- Raised 2026 revenue guidance to $210-220 million with $300 million annualized run-rate expected by year-end.

## Latest updates

- **2026-07** — IM8 secured $1 billion in non-dilutive growth financing from General Catalyst's Customer Value Fund and raised full-year 2026 revenue guidance to $210-220 million.
- **2026-06** — Reported roughly $17 million in preliminary monthly revenue and about 200,000 servings delivered daily.

## Links

- Website: https://im8health.com
- LinkedIn: https://www.linkedin.com/company/im8health/
- Instagram: https://www.instagram.com/im8health/

---

Profile page: https://yespress.io/im8-beckham-1b-general-catalyst-cvf
Published by YesPress — https://yespress.io
Last updated: 2026-07-15